WITHUS PHARMACEUTICAL Co.,LTD. (KOSDAQ: 330350)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,310.00
+90.00 (1.45%)
Nov 15, 2024, 9:00 AM KST

WITHUS PHARMACEUTICAL Co.,LTD. Revenue

WITHUS PHARMACEUTICAL Co.,LTD. had revenue of 26.26B KRW in the quarter ending June 30, 2024, with 44.82% growth. This brings the company's revenue in the last twelve months to 98.27B, up 49.37% year-over-year. In the year 2023, WITHUS PHARMACEUTICAL Co.,LTD. had annual revenue of 80.12B with 23.87% growth.

Revenue (ttm)
98.27B
Revenue Growth
+49.37%
P/S Ratio
0.84
Revenue / Employee
812.18M
Employees
121
Market Cap
82.38B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202380.12B15.44B23.87%
Dec 31, 202264.68B7.26B12.65%
Dec 31, 202157.42B4.01B7.51%
Dec 31, 202053.41B1.01B1.93%
Jun 30, 202052.39B661.12M1.28%
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro
Jun 30, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition